Topcon 3D OCT-1 Maestro / Maestro2
Modality: Ophthalmic OCT
Topcon's mainstream spectral-domain OCT with integrated color fundus camera — the workhorse retinal-imaging platform for community ophthalmology, optometry, and high-volume diabetic-retinopathy screening. Direct competitor to the Zeiss Cirrus mainstream tier. Maestro2 (current generation) refreshes the Maestro platform with faster acquisition and updated analytics.
Distinctive technology
- Spectral-domain OCT at 840 nm — mainstream retinal-imaging spectrum.
- Integrated color fundus camera — paired fundus + OCT in single-acquisition workflow; simplifies high-volume retinal screening.
- Auto-alignment + auto-focus — minimizes operator-skill dependence; useful in non-specialty / optometry settings.
- Single-button operation — designed for technician / non-physician operator workflow.
- Harmony image-management integration for AI-assisted screening.
Clinical use
- Retinal screening — diabetic retinopathy, AMD detection, glaucoma RNFL analysis.
- High-volume optometry / community ophthalmology — single-acquisition workflow fits non-specialty settings.
- Telemedicine — paired fundus + OCT acquisitions support remote-reading workflows.
Refurb posture
- Strong refurb supply — Maestro turnover in optometry / community-ophthalmology upgrades feeds the secondary market.
- Software-version status drives analytics capability.
- Vendor lock-in on serial patient comparison.